Retraction
Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques
Paper Information
Record ID:
27524
Author(s):
Publication Date:
February 15, 2020
Retraction Date:
April 15, 2021
(4.6 years years ago)
Subjects:
Institutions:
- Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana
- University of Florida College of Pharmacy, Gainesville, Florida
- Rollins School of Public Health, Emory University, Atlanta, Georgia
- Emory Vaccine Center and Yerkes National Primate Center, Emory University, Atlanta, Georgia
- Department of Microbiology and Immunology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
- Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, California
- Southwest National Primate Research Center, Texas Biomedical Research Center, San Antonio, Texas
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Thoracic Society
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1164/rccm.v203retraction1Additional Notes:
see: https://ori.hhs.gov/content/case-summary-kaushal-deepak
Citations (17)
17
Total Citations4
Post-Retraction(23.5%)
12
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
635
Days since retraction (latest)
Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus
Kaiyu Cui, Weifeng Yang, Zhiyuan Liu et al. (14 authors)
Microbiology Spectrum
Open Access
Published: Jan 2023
9 citations
9 citations
635 days after retraction
Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs
Riti Sharan, Shashank Ganatra, Dhiraj Kumar Singh et al. (17 authors)
Journal of Clinical Investigation
Open Access
Published: Jul 2022
15 citations
15 citations
462 days after retraction
Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis
Juan F. Vesga, Christian Lienhardt, Placide Nsengiyumva et al. (10 authors)
BMC Medicine
Open Access
Published: May 2022
3 citations
3 citations
398 days after retraction
Assay design for unambiguous identification and quantification of circulating pathogen-derived peptide biomarkers
Qingbo Shu, Shan Liu, Tonino Alonzi et al. (13 authors)
Theranostics
Open Access
Published: Jan 2022
7 citations
7 citations
261 days after retraction
Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent <i>Mycobacterium tuberculosis</i> in Macaques
Unknown Authors
American Journal of Respiratory and Critical Care Medicine
Open Access
Published: Apr 2021
Same day as retraction
One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics
Hee‐Jeong Yang, Decheng Wang, Xin Wen et al. (5 authors)
Frontiers in Cellular and Infection Microbiology
Open Access
Published: Mar 2021
31 citations
31 citations
30 days before retraction
Reply to Aberegg and Wolfe: Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
Laura Loughlin, Daniel F. McAuley, A. John Simpson et al. (4 authors)
American Journal of Respiratory and Critical Care Medicine
Open Access
Published: Jan 2021
79 days before retraction
The immune landscape in tuberculosis reveals populations linked to disease and latency
Ekaterina Esaulova, Shibali Das, Dhiraj Kumar Singh et al. (21 authors)
Cell Host & Microbe
Open Access
Published: Dec 2020
160 citations
160 citations
118 days before retraction
Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets
Dhiraj Kumar Singh, Bindu Singh, Shashank Ganatra et al. (62 authors)
Nature Microbiology
Open Access
Published: Dec 2020
193 citations
193 citations
118 days before retraction
Treatment of latent M. tuberculosis infection and use of antiretroviral therapy to prevent tuberculosis
Timothy R. Sterling, Philana Ling Lin
Journal of Clinical Investigation
Open Access
Published: Aug 2020
4 citations
4 citations
235 days before retraction
Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment
Uma Shanmugasundaram, Allison N. Bucşan, Shashank Ganatra et al. (10 authors)
JCI Insight
Open Access
Published: Jun 2020
73 citations
73 citations
302 days before retraction
Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model
Shashank Ganatra, Allison N. Bucşan, Xavier Álvarez et al. (17 authors)
Journal of Clinical Investigation
Open Access
Published: Jun 2020
42 citations
42 citations
303 days before retraction
SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species
Dhiraj Kumar Singh, Shashank Ganatra, Bindu Singh et al. (58 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2020
33 citations
33 citations
314 days before retraction
Advances in tuberculosis in 2019 in Canada and globally
Dick Menzies
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Published: Mar 2020
385 days before retraction
Nuevos enfoques en investigación de la infección tuberculosa latente
Patricio Escalante, Miguel Arias-Guillén, Juan J. Palacios
Archivos de Bronconeumología
Published: Mar 2020
2 citations
2 citations
394 days before retraction
Control of Mycobacterium tuberculosis Infection in Lungs is Associated with Recruitment of Antigen-Specific Th1 and Th17 cells Co-expressing CXCR3 and CCR6
Uma Shanmugasundaram, Allison N. Bucşan, Shashank Ganatra et al. (10 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2020
4 citations
4 citations
401 days before retraction
Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?
Andrew Vernon, William R. Bishai
American Journal of Respiratory and Critical Care Medicine
Open Access
Published: Nov 2019
2 citations
2 citations
507 days before retraction
Quick Stats
Total Citations:
17
Years Since Retraction:
4.6 years
Open Access:
Yes
Last Checked:
Jul 24, 2025